1.510EUR0.00%Mkt Cap: 58.94M $P/E: —2d ago
Pangaea Oncology, S.A., a medical services company, provides a range of services to cancer patients in Spain and the rest of European Union countries. It offers molecular diagnostics, such as mutation analysis in tissue …
Indicators:|
Key Statistics
Company
Market Cap58.94M $
Enterprise Value61.86M $
Revenue (TTM)18.19M $
Gross Profit15.67M $
Net Income (TTM)-3.91M $
Revenue/Share0.5065 USD
Last Price1.510 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2024
Employees159
CountryES
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)Infinity
PEG—
EV/EBITDA-21.87
EV/Revenue3.40
P/S3.24
P/B2.55
EPS (TTM)-0.10
EPS (Forward)0.00
52W Range
1.5100% of range1.750
52W High1.750 EUR
52W Low1.510 EUR
Profitability
Gross Margin99.28%
Oper. Margin-20.63%
EBITDA Margin-15.55%
Profit Margin-24.76%
ROE-16.88%
ROA-11.20%
Growth
Revenue Growth139.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.74M $
CapEx (TTM)513.57K $
FCF Margin-5.17%
FCF Yield-1.60%
Net Debt2.22M $
Net Debt/EBITDA-0.78
Balance Sheet
Debt/Equity0.27
Current Ratio1.78
Quick Ratio1.47
Book Value/Sh0.5930 EUR
Cash/Share0.0520 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.35.91M
Float10.87M
Insiders69.32%
Institutions0.34%
Technical
SMA 501.594 (-5.3%)
SMA 2001.671 (-9.6%)
Beta0.01
S&P 52W Chg20.05%
Avg Vol (30d)7.96K
Avg Vol (10d)902
Technical Indicators
RSI (14)38.3
MACD-0.0193
MACD Signal-0.0133
MACD Hist.-0.0061
BB Upper1.643 EUR
BB Middle1.571 EUR
BB Lower1.498 EUR
BB Width9.18%
ATR (14)0.0257 EUR
Vol Ratio (20d)0.00x